NEARLY EVERY CONDITION IMPACTING OUR HEALTH HAS TIES TO OUR GENOME.
MEDICINE HAS BEEN EVOLVING FROM SYMPTOM-BASED, TO PATTERN-BASED, AND IS NOW ALGORITHM-DRIVEN. SNIPPET TRANSLATES THE LATEST GENOMIC RESEARCH TO PROVIDERS AND ULTIMATELY PATIENTS.
Personalized medicine starts with pharmacogenomics.
Over 400,000 genotype-phenotype interactions have been submitted to national research knowledgebases, yet only 23 have clinical guidelines. While new clinically-validated drug-gene interactions are continuously discovered, less than 25% of providers have an active pharmacogenomics program. At the same time, over 1.5 million patients each year are impacted by adverse drug reactions, leading to an avoidable cost of over $3.5M annually. Snippet is solving this problem.